Angela M. Cacace, Chief Scientific Officer at ARVINAS, INC. (ARVN), sold 3,609 shares at $12.16 ($44K) on 2026-02-23, disclosed to the SEC on 2026-02-25.
Open-market sale of $44k ARVN by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.16 | 1,038 | $13K | 28.8% |
| 2 | $12.16 | 2,571 | $31K | 71.2% |
| Total | $12.16 avg | 3,609 | $44K | 100% |
| Filing → |
| ARVN | SELL | 2026-02-18 | $55K | — | Filing → |
| ARVN | SELL | 2025-06-18 | $19K | — | Filing → |
| ARVN | SELL | 2025-02-25 | $122K | — | Filing → |